Charu Aggarwal, MD, MPH, FASCO

Cancer.Net Associate Editor: Lung Cancer
University of Pennsylvania, Philadelphia, PA

Dr. Charu Aggarwal is the Leslye Heisler Associate Professor of Medicine in the Hematology-Oncology Division at the University of Pennsylvania’s Perelman School of Medicine. She is an active member of the Abramson Cancer Center (ACC) where she serves as Physician Leader for the clinical research program for airways malignancies.

Dr. Aggarwal attended Lady Hardinge Medical College and completed her residency at the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo. She completed her fellowship at Fox Chase Cancer Center in Philadelphia.

Dr. Aggarwal specializes in the management of people with lung cancer, with a specific and clinical research focus on the development of novel immunotherapeutic approaches, and the discovery and application of biomarkers to guide therapy and monitor treatment. She serves as the local and national principal investigator for multiple clinical trials focusing on the development of “targeted” immunotherapeutic approaches including cellular therapy and CAR-T for solid tumors. Dr. Aggarwal has led clinical trials evaluating the role of plasma-based next generation sequencing in the management of patients with metastatic lung cancer.

She has extensive experience in the planning, design and execution of clinical trials, is an active member of the Eastern Cooperative Oncology Group (ECOG), and has served as a national sub-study chair for SWOG-National Cancer Institute’s LUNG-MAP. She has served on ASCO’s Annual Meeting Scientific Program Committee and the ASCO Education Committee, and she is a selected participant of the ASCO Leadership Development Program’s class of 2020. Dr. Aggarwal’s ultimate goal as a clinical and translational investigator is to perform patient-centered, scientifically relevant novel immunotherapy clinical trials that will make a tangible impact and advance the understanding of immunotherapy in patients with lung cancer.

View current ASCO disclosure here.

Last updated: July 2021